The METEX Study: Comparing Methotrexate and Expectant Management for Ectopic Pregnancy
Author Information
Author(s): van Mello Norah M, Mol Femke, Adriaanse Albert H, Boss Erik A, Dijkman Antonius B, Doornbos Johannes PR, Emanuel Mark Hans, Friederich Jaap, Leeuw-Harmsen Loes van der, Lips Jos P, van Santbrink Evert JP, Verhoeve Harold R, Visser Harry, Ankum Willem M, Veen Fulco van der, Mol Ben W, Hajenius Petra J
Primary Institution: Academic Medical Centre, University of Amsterdam
Hypothesis
Is expectant management an effective alternative to methotrexate treatment in women with ectopic pregnancy or pregnancy of unknown location and low plateauing serum hCG levels?
Conclusion
The study aims to determine if expectant management can be as effective as methotrexate treatment for women with specific types of ectopic pregnancies.
Supporting Evidence
- Ectopic pregnancy is diagnosed using sensitive pregnancy tests and high-resolution ultrasound.
- Expectant management may allow for spontaneous resolution of early ectopic pregnancies.
- Methotrexate treatment is typically reserved for selected patients with ectopic pregnancies.
Takeaway
This study is trying to find out if waiting and watching is just as good as giving medicine for some women with ectopic pregnancies.
Methodology
A multicentre randomised controlled trial comparing expectant management with a single dose of methotrexate in women with ectopic pregnancy or pregnancy of unknown location.
Potential Biases
Potential bias in patient selection and reporting of outcomes.
Limitations
The study may not include all women with ectopic pregnancies, as certain criteria exclude those with viable pregnancies or signs of complications.
Participant Demographics
Women aged 18 and older with ectopic pregnancy or pregnancy of unknown location.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website